Health insurance coverage
California employers could have to cover weight-loss treatment
Starting Jan. 1, 2027, large-group plans would need to treat weight loss as a medical condition. If they already cover outpatient drugs, they would also have to include at least one FDA-approved antiobesity medication.
California’s SB 1089 would set a coverage floor for large-group health plans. It would require weight-loss treatment and, for plans with outpatient prescription benefits, at least one FDA-approved antiobesity drug.
- Large-group plans would have to cover weight loss as a medical condition.
- The change would begin with contracts issued, amended or renewed on or after Jan. 1, 2027.
- Plans with outpatient drug benefits would need at least one FDA-approved antiobesity medication.
- Specialized health care service plans are excluded.
- In California, large-group health plans would have to treat weight loss as a covered medical condition starting with contracts issued, amended or renewed on or after Jan
In California, large-group health plans would have to treat weight loss as a covered medical condition starting with contracts issued, amended or renewed on or after Jan. 1, 2027. Senator Laura Richardson’s Preventive Treatment Health Care Act would add that requirement to the state’s existing benefit rules, pushing the issue from a workplace perk into standard insurance coverage.
A new floor for large-group plans
The practical change is that people in large employer plans would no longer have to hope their coverage happens to include weight-loss treatment. The bill would make that care part of the contract itself, so the benefit is built into the plan rather than left to chance or a particular employer’s choices.
That matters most for enrollees who see obesity as a medical problem that deserves treatment through regular insurance, not as an extra service they may or may not be able to afford on their own.
The drug benefit follows the coverage
If a plan includes outpatient prescription drug benefits, it would also have to cover at least one antiobesity medication approved by the U.S. Food and Drug Administration. The bill does not spell out a full drug formulary, but it does make clear that medication would be part of the required package for plans already covering outpatient prescriptions.
The text also points to body mass index, or BMI, as a screening formula, underscoring that the proposal is aimed at obesity-related care. It does not apply to specialized health care service plan contracts, which narrows the reach of the mandate.
What stays outside the mandate
For insurers, the central question would be how to build the new benefit into contracts without losing the distinction between a general large-group plan and a specialized product. For workers and families, the larger effect is simpler: if the bill becomes law, weight-loss care would no longer sit outside the normal health-coverage conversation for many employer plans.